Related references
Note: Only part of the references are listed.Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation
Heyu Song et al.
CANCER LETTERS (2021)
Ewing's Sarcoma
Nicolo Riggi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
Oxana Schmidt et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma
Didier Surdez et al.
CANCER CELL (2021)
Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists
Jialin Mo et al.
CANCER RESEARCH (2021)
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao et al.
CLINICAL CANCER RESEARCH (2021)
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma
Guillermo Flores et al.
JOURNAL OF BONE ONCOLOGY (2021)
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
Biniam Adane et al.
CANCER CELL (2021)
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A. Seong et al.
CANCER CELL (2021)
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
Shunya Ohmura et al.
MOLECULAR CANCER (2021)
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia
Klaartje Somers et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M. Amin et al.
CANCERS (2020)
The role of FACT in managing chromatin: disruption, assembly, or repair?
Tim Formosa et al.
NUCLEIC ACIDS RESEARCH (2020)
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
Sara Sanchez-Molina et al.
SCIENCE ADVANCES (2020)
Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
Jiajia Wang et al.
CELL DEATH & DISEASE (2020)
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion
Sabine Heitzeneder et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Sudan N. Loganathan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
Sarah Wang et al.
CLINICAL CANCER RESEARCH (2019)
CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists
Fang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Julian Musa et al.
NATURE COMMUNICATIONS (2019)
Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1
Lehang Lin et al.
NUCLEIC ACIDS RESEARCH (2019)
RNA polymerase II is released from the DNA template during transcription-coupled repair in mammalian cells
Yi-Ying Chiou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins
Paradesi Naidu Gollavilli et al.
CANCER RESEARCH (2018)
MicroRNA-365 modulates astrocyte conversion into neuron in adult rat brain after stroke by targeting Pax6
Jia-Lin Mo et al.
GLIA (2018)
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response
Kathleen I. Pishas et al.
MOLECULAR CANCER THERAPEUTICS (2018)
EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesis
Nirmalya Sen et al.
MOLECULAR CARCINOGENESIS (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies
Gaylor Boulay et al.
GENES & DEVELOPMENT (2018)
Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins
Han-Wen Chang et al.
SCIENCE ADVANCES (2018)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
Julia Joung et al.
NATURE PROTOCOLS (2017)
Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo
Andreas Kirschner et al.
ONCOIMMUNOLOGY (2017)
Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas
Minhyung Kim et al.
CANCER RESEARCH (2016)
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma
Salah-Eddine Lamhamedi-Cherradi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner et al.
NATURE METHODS (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma
Kelli L. Goss et al.
ONCOTARGET (2016)
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma
Salah-Eddine Lamhamedi-Cherradi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Thomas G. P. Gruenewald et al.
NATURE GENETICS (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
Eleni M. Tomazou et al.
CELL REPORTS (2015)
Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour-stromal interactions: a report from the Children's Oncology Group
Samuel L. Volchenboum et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
Nicolo Riggi et al.
CANCER CELL (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
Sven Bilke et al.
GENOME RESEARCH (2013)
Microarray Analysis Reveals Novel Features of the Muscle Aging Process in Men and Women
Dongmei Liu et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data
Jianxing Feng et al.
BIOINFORMATICS (2012)
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
Sophie Postel-Vinay et al.
NATURE GENETICS (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
Overcoming Resistance to Conventional Drugs in Ewing Sarcoma and Identification of Molecular Predictors of Outcome
Katia Scotlandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
Guenther H. S. Richter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature
Jeffrey D. Hancock et al.
CELL CYCLE (2008)
EWS-Fli1 Up-Regulates Expression of the Aurora A and Aurora B Kinases
Kazuhiko Wakahara et al.
MOLECULAR CANCER RESEARCH (2008)
Microsatellites as EWIS/FLI response elements in Ewing's sarcoma
Kunal Gangwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Gene expression analyses reveal molecular relationships among 20 regions of the human CNS
RB Roth et al.
NEUROGENETICS (2006)
Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor
Ana S. Martins et al.
CLINICAL CANCER RESEARCH (2006)
EWS-ETS oncoproteins: The linchpins of Ewing tumors
R Janknecht
GENE (2005)
Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma
M Fukuma et al.
ONCOGENE (2003)
Share Paper
